US4160452A
(en)
|
1977-04-07 |
1979-07-10 |
Alza Corporation |
Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
DE3825867A1
(de)
|
1988-03-04 |
1989-09-14 |
Bayer Ag |
Heterocyclisch substituierte sulfonylaminoazole und ihre verwendung als herbizide
|
EP0409332A3
(en)
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
DE3928605A1
(de)
*
|
1989-08-30 |
1991-03-07 |
Bayer Ag |
Substituierte sulfonylaminoazole
|
JP2726563B2
(ja)
|
1990-02-13 |
1998-03-11 |
メルク・エンド・カムパニー・インコーポレーテツド |
置換ベンジル要素を含むトリアゾールアンギオテンシン▲ii▼拮抗物質
|
JPH0511439A
(ja)
|
1990-09-13 |
1993-01-22 |
Fuji Photo Film Co Ltd |
光重合性組成物
|
DE4035141A1
(de)
|
1990-11-06 |
1992-05-07 |
Bayer Ag |
Substituierte sulfonylaminotriazolylpyrimidine
|
CZ283018B6
(cs)
|
1991-02-01 |
1997-12-17 |
Merck Sharp And Dohme Limited |
Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
|
SE9103397D0
(sv)
|
1991-11-18 |
1991-11-18 |
Kabi Pharmacia Ab |
Nya substituerade salicylsyror
|
ATE205202T1
(de)
|
1992-03-13 |
2001-09-15 |
Merck Sharp & Dohme |
Imidazol-, triazol- und tetrazolderivate
|
US5411839A
(en)
|
1993-01-15 |
1995-05-02 |
Eastman Kodak Company |
Image formation in color reversal materials using strong inhibitors
|
PL185872B1
(pl)
|
1995-02-03 |
2003-08-29 |
Upjohn Co |
Nowe podstawione fenylooksazolidynonyNowe podstawione fenylooksazolidynony
|
US5563026A
(en)
|
1995-04-28 |
1996-10-08 |
Eastman Kodak Company |
Color negative element having improved green record printer compatibility
|
JP3788676B2
(ja)
|
1997-11-11 |
2006-06-21 |
富士写真フイルム株式会社 |
有機エレクトロルミネツセンス素子材料およびそれを使用した有機エレクトロルミネツセンス素子
|
CA2315735A1
(fr)
|
1998-02-13 |
1999-08-19 |
Michael R. Barbachyn |
Derives d'isoxazoline aminophenyle substitues utilises comme agents antimicrobiens
|
EP1060179A1
(fr)
|
1998-02-25 |
2000-12-20 |
PHARMACIA & UPJOHN COMPANY |
Derives d'isoxazoline aminomethyle substitues utiles en tant qu'agents antimicrobiens
|
EE200200123A
(et)
|
1999-09-10 |
2003-08-15 |
Merck & Co., Inc. |
Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning raviotstarbeline kasutamine
|
US6555693B2
(en)
|
2000-03-16 |
2003-04-29 |
Genesoft, Inc. |
Charged compounds comprising a nucleic acid binding moiety and uses therefor
|
CN1419563A
(zh)
|
2000-03-23 |
2003-05-21 |
武田药品工业株式会社 |
肽衍生物
|
PL359340A1
(en)
|
2000-05-19 |
2004-08-23 |
|
Triazole derivatives
|
WO2002053160A1
(fr)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Methode de traitement du glaucome ivb
|
WO2002053101A2
(fr)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Procede de traitement de troubles fibrogenes et autres symptomes de type ivc
|
US6727364B2
(en)
|
2001-04-30 |
2004-04-27 |
The Procter & Gamble Company |
Triazole compounds useful in treating diseases associated with unwanted cytokine activity
|
US6787555B2
(en)
|
2001-04-30 |
2004-09-07 |
The Procter & Gamble Company |
Triazole compounds useful in treating diseases associated with unwanted cytokine activity
|
US6790846B2
(en)
|
2001-05-24 |
2004-09-14 |
The Procter & Gamble Company |
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
|
JP2003005356A
(ja)
|
2001-06-20 |
2003-01-08 |
Fuji Photo Film Co Ltd |
電子線又はx線用ネガ型レジスト組成物
|
DE10138569A1
(de)
|
2001-08-06 |
2003-04-30 |
Bayer Ag |
Regulation des APJ-Rezeptors
|
JP2003321456A
(ja)
|
2002-04-30 |
2003-11-11 |
Fuji Photo Film Co Ltd |
5−アミノ−4−含窒素芳香族ヘテロ環置換ピラゾール類の製造方法
|
WO2004030611A2
(fr)
|
2002-08-23 |
2004-04-15 |
Ribapharm Inc. |
Inhibiteurs non nucleosidiques de transcriptases inverses
|
US7084145B2
(en)
|
2002-10-25 |
2006-08-01 |
Pfizer Inc. |
Triazole compounds useful in therapy
|
AU2003300099A1
(en)
|
2003-01-02 |
2004-07-29 |
Millennium Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING TGF-Beta
|
US20040167188A1
(en)
|
2003-02-14 |
2004-08-26 |
Zhili Xin |
Protein-tyrosine phosphatase inhibitors and uses thereof
|
US7169797B2
(en)
|
2003-02-14 |
2007-01-30 |
Abbott Laboratories |
Protein-tyrosine phosphatase inhibitors and uses thereof
|
WO2004078923A2
(fr)
|
2003-02-28 |
2004-09-16 |
Plexxikon, Inc. |
Structure cristalline de pyk2 et ses utilisations
|
WO2005004818A2
(fr)
|
2003-07-09 |
2005-01-20 |
Imclone Systems Incorporated |
Composes heterocycliques et leur utilisation comme agents anticancereux
|
EP1664052B1
(fr)
|
2003-08-15 |
2009-02-18 |
AstraZeneca AB |
Heterocycles fusionnes utilises en tant qu'inhibiteurs de la glutamate racemase (muri)
|
CA2542682A1
(fr)
|
2003-10-18 |
2005-05-06 |
Bayer Healthcare Ag |
Derives de 2-(phenylmethyl)thio-4-phenyl-4h-1,2,4-triazole substitues en 5 et composes associes utilises en tant que gaba-agonistes dans le traitement de l'incontinence urinaire et des maladies associees
|
JP2005170939A
(ja)
|
2003-11-20 |
2005-06-30 |
Takeda Chem Ind Ltd |
糖尿病の予防・治療剤
|
WO2005073193A1
(fr)
|
2004-01-23 |
2005-08-11 |
Amgen Inc. |
Ligands du recepteur vanilloide et leur utilisation dans des traitements
|
US7297168B2
(en)
|
2004-02-02 |
2007-11-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
JP2007530589A
(ja)
|
2004-03-26 |
2007-11-01 |
アンフォラ ディスカバリー コーポレーション |
特定のトリアゾールを基礎とする化合物、組成物、およびそれらの使用
|
WO2005123672A2
(fr)
|
2004-06-14 |
2005-12-29 |
Takeda San Diego, Inc. |
Inhibiteurs de kinase
|
US7399317B2
(en)
|
2004-08-26 |
2008-07-15 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
KR101214665B1
(ko)
|
2004-09-16 |
2012-12-21 |
아스텔라스세이야쿠 가부시키가이샤 |
트리아졸 유도체 또는 그의 염
|
CN101072759B
(zh)
|
2004-11-18 |
2013-06-19 |
Synta医药公司 |
调节hsp90活性的三唑化合物
|
US20060156480A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
WO2006080533A1
(fr)
|
2005-01-31 |
2006-08-03 |
Mochida Pharmaceutical Co., Ltd. |
Dérivé de 3-amino-1,2,4-triazole
|
RU2007137133A
(ru)
|
2005-03-09 |
2009-04-20 |
Ниппон Каяку Кабусики Кайся (Jp) |
Новый ингибитор hsp90
|
US8399464B2
(en)
|
2005-03-09 |
2013-03-19 |
Nippon Kayaku Kabushiki Kaisha |
HSP90 inhibitor
|
WO2006100588A1
(fr)
|
2005-03-21 |
2006-09-28 |
Pfizer Limited |
Derives de triazole substitues utilises en tant qu'antagonistes d'oxytocine
|
AU2006235759B2
(en)
|
2005-04-06 |
2011-07-28 |
Msd K.K. |
1,4-substituted piperazine derivative
|
WO2007007688A1
(fr)
|
2005-07-08 |
2007-01-18 |
Mochida Pharmaceutical Co., Ltd. |
Dérivé de 3,5-diamino-1,2,4-triazole
|
WO2007021941A2
(fr)
|
2005-08-16 |
2007-02-22 |
Icagen, Inc. |
Inhibiteurs des canaux sodium sensibles au voltage
|
EP1917251B1
(fr)
|
2005-08-21 |
2013-04-03 |
Abbott GmbH & Co. KG |
Composes 5-cycle-heteroaromates et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
|
US8673848B2
(en)
|
2012-01-27 |
2014-03-18 |
Novartis Ag |
Synthetic apelin mimetics for the treatment of heart failure
|
ZA200807263B
(en)
|
2006-04-19 |
2009-11-25 |
Serono Lab |
Novel heteroaryl-substituted arylaminopyrldine derivatives as MEK inhibitors
|
ES2484042T3
(es)
|
2006-05-25 |
2014-08-08 |
Synta Pharmaceuticals Corporation |
Compuestos de triazol que modulan la actividad de HSP90
|
WO2007139951A2
(fr)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Procédé pour traiter des troubles proliférants associés à des produits protooncogènes
|
CA2653222A1
(fr)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Composes de triazole qui modulent l'activite de la hsp90
|
US8063083B2
(en)
|
2006-05-25 |
2011-11-22 |
Synta Pharmaceuticals Corp. |
Method for treating non-Hodgkin's lymphoma
|
AU2012200157B2
(en)
|
2006-05-25 |
2014-08-21 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
US20080125587A1
(en)
|
2006-05-25 |
2008-05-29 |
Chimmanamada Dinesh U |
Synthesis of triazole compounds that modulate HSP90 activity
|
EP2038272B8
(fr)
|
2006-06-30 |
2013-10-23 |
Sunesis Pharmaceuticals, Inc. |
Inhibiteurs de pyridinonyle pdk1
|
WO2008008375A2
(fr)
|
2006-07-14 |
2008-01-17 |
Chemocentryx, Inc. |
Triazolyl pyridyl benzènesulfonamides
|
US7718683B2
(en)
|
2006-07-14 |
2010-05-18 |
Chemocentryx, Inc. |
Triazolyl phenyl benzenesulfonamides
|
JP5480623B2
(ja)
|
2006-08-17 |
2014-04-23 |
シンタ ファーマシューティカルズ コーポレーション |
Hsp90活性を調節するトリアゾール化合物
|
US20110046125A1
(en)
|
2006-10-19 |
2011-02-24 |
Synta Pharmaceuticals Corp. |
Method for treating infections
|
WO2008057246A2
(fr)
|
2006-10-26 |
2008-05-15 |
Synta Pharmaceuticals Corp. |
Procédé de traitement de troubles inflammatoires
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
JP5523839B2
(ja)
|
2007-02-08 |
2014-06-18 |
シンタ ファーマシューティカルズ コーポレーション |
癌などの増殖障害の治療に有用なトリアゾール化合物
|
US7909187B2
(en)
|
2007-02-20 |
2011-03-22 |
Lonzell Montgomery |
Modular baby bottle system
|
WO2008112199A1
(fr)
|
2007-03-12 |
2008-09-18 |
Synta Pharmaceuticals Corp. |
Procédé d'inhibition de la topoisomérase ii
|
WO2008153730A2
(fr)
|
2007-05-25 |
2008-12-18 |
Synta Pharmaceuticals Corp. |
Méthode de traitement des maladies prolifératives associées à des mutations dans c-met
|
CN101801942B
(zh)
|
2007-07-17 |
2013-03-27 |
美国艾森生物科学公司 |
杂环化合物和作为抗癌剂的用途
|
EP2193135A1
(fr)
|
2007-08-13 |
2010-06-09 |
Synta Pharmaceuticals Corp. |
Composés de triazole qui modulent l'activité de hsp90
|
TW200922564A
(en)
|
2007-09-10 |
2009-06-01 |
Curis Inc |
CDK inhibitors containing a zinc binding moiety
|
WO2009075890A2
(fr)
|
2007-12-12 |
2009-06-18 |
Synta Pharmaceuticals Corp. |
Composés triazole qui modulent l'activité de hsp90
|
US7820665B2
(en)
|
2007-12-19 |
2010-10-26 |
Amgen Inc. |
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
|
DE102008013587A1
(de)
|
2008-03-11 |
2009-09-17 |
Bayer Schering Pharma Aktiengesellschaft |
Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
|
EP2103602A1
(fr)
|
2008-03-17 |
2009-09-23 |
AEterna Zentaris GmbH |
Nouveaux dérivés de triazole 1,2,4 et leur processus de fabrication
|
US9029376B2
(en)
|
2008-06-03 |
2015-05-12 |
Siga Technologies, Inc. |
Small molecule inhibitors for the treatment or prevention of dengue virus infection
|
JP5615274B2
(ja)
|
2008-07-01 |
2014-10-29 |
ジェネンテック, インコーポレイテッド |
Mekキナーゼインヒビターとしてのイソインドロン誘導体及びその使用方法
|
MX2010014559A
(es)
|
2008-07-01 |
2011-03-04 |
Genentech Inc |
Heterociclos bicíclicos sustituidos y metodos de uso.
|
WO2010017545A2
(fr)
|
2008-08-08 |
2010-02-11 |
Synta Pharamceuticals Corp. |
Composés de triazole qui modulent l'activité hsp90
|
DE102008038221A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
7-Azaindolderivate
|
CA2744817C
(fr)
|
2008-11-26 |
2020-07-07 |
Satiogen Pharmaceuticals, Inc. |
Inhibiteurs de recyclage de l'acide biliaire pour le traitement de l'obesite et du diabete
|
DE102008059702A1
(de)
|
2008-12-01 |
2010-06-02 |
Byk-Chemie Gmbh |
Verfahren zur Herstellung rheologisch wirksamer Harnstoffurethane in organischen Salzen
|
EP2438052A1
(fr)
|
2009-06-05 |
2012-04-11 |
Oslo University Hospital HF |
Dérivés d'azole en tant qu'inhibiteurs de la voie wnt
|
WO2010144338A1
(fr)
|
2009-06-08 |
2010-12-16 |
Abraxis Bioscience, Llc |
Dérivés de triazine et leurs applications thérapeutiques
|
EP2509960A1
(fr)
|
2009-12-11 |
2012-10-17 |
Exelixis, Inc. |
Agonistes de tgr5
|
KR102113960B1
(ko)
|
2010-03-30 |
2020-05-21 |
베르선 코포레이션 |
트롬빈 억제제로서의 다중치환된 방향족 화합물
|
US9205086B2
(en)
|
2010-04-19 |
2015-12-08 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
|
US20130156755A1
(en)
|
2010-04-19 |
2013-06-20 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
|
US20130172333A1
(en)
|
2010-05-20 |
2013-07-04 |
Synta Pharmaceuticals Corp. |
Formulation and dosing of hsp90 inhibitory compounds
|
ES2552657T3
(es)
|
2010-05-26 |
2015-12-01 |
Satiogen Pharmaceuticals, Inc. |
Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias
|
BR112013000925A2
(pt)
|
2010-07-15 |
2020-12-01 |
Bayer Intellectual Property Gmbh |
compostos heterocíclicos como pesticidas
|
WO2012021778A2
(fr)
|
2010-08-12 |
2012-02-16 |
The Regents Of The University Of California |
Procédés de blocage de la prolifération cellulaire et de traitement de maladies et d'affections répondant à une inhibition de la croissance cellulaire
|
US9096587B2
(en)
|
2010-12-08 |
2015-08-04 |
Oslo University Hospital Hf |
Triazole derivatives as Wnt signaling pathway inhibitors
|
US20140045908A1
(en)
|
2011-02-25 |
2014-02-13 |
Synta Pharmaceuticals Corp. |
Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers
|
EP2739286A4
(fr)
|
2011-08-04 |
2015-06-03 |
Lumena Pharmaceuticals Inc |
Inhibiteurs du recyclage de l'acide biliaire dans le traitement du pancréas
|
WO2013032939A1
(fr)
|
2011-08-26 |
2013-03-07 |
Metabolex, Inc. |
Agonistes bicycliques de gpr131 et leurs utilisations
|
US20130108573A1
(en)
|
2011-10-28 |
2013-05-02 |
Lumena Pharmaceuticals, Inc. |
Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
|
EA201891154A1
(ru)
|
2011-10-28 |
2019-02-28 |
ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи |
Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
|
CA2853806C
(fr)
|
2011-11-02 |
2020-07-14 |
Synta Pharmaceuticals Corp. |
Polytherapie d'inhibiteurs de hsp 90 avec des agents contenant du platine
|
EP2773345A1
(fr)
|
2011-11-02 |
2014-09-10 |
Synta Pharmaceuticals Corp. |
Thérapie anticancéreuse utilisant une combinaison d'inhibiteurs de hsp 90 et d'inhibiteurs de topoisomérase i
|
AU2012339679A1
(en)
|
2011-11-14 |
2014-06-12 |
Synta Pharmaceuticals Corp. |
Combination therapy of Hsp90 inhibitors with BRAF inhibitors
|
US20150011466A1
(en)
|
2012-01-09 |
2015-01-08 |
Anchor Therapeutics, Inc. |
APJ Receptor Compounds
|
US8987311B2
(en)
|
2012-01-13 |
2015-03-24 |
Bristol-Myers Squibb Company |
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
JP2015515469A
(ja)
|
2012-03-28 |
2015-05-28 |
シンタ ファーマシューティカルズ コーポレーション |
Hsp90阻害剤としてのトリアゾール誘導体
|
AU2013271731A1
(en)
|
2012-06-07 |
2014-12-18 |
Georgia State University Research Foundation, Inc. |
SecA inhibitors and methods of making and using thereof
|
US20140005181A1
(en)
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
JP6186438B2
(ja)
|
2012-09-21 |
2017-08-23 |
サノフイ |
Apj受容体モジュレーターとしてのベンゾイミダゾールカルボン酸アミド誘導体
|
JP6426107B2
(ja)
|
2012-12-20 |
2018-11-21 |
アムジエン・インコーポレーテツド |
Apj受容体アゴニストおよびその使用
|
AU2014237312B2
(en)
|
2013-03-15 |
2019-03-28 |
Shifa Biomedical Corporation |
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
|
UY35517A
(es)
|
2013-04-04 |
2014-10-31 |
Mabxience S A |
Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
|
CN105682665A
(zh)
|
2013-05-30 |
2016-06-15 |
华盛顿大学 |
用于治疗细菌性感染的化合物和方法
|
WO2015140296A2
(fr)
|
2014-03-20 |
2015-09-24 |
Centre National De La Recherche Scientifique (Cnrs) |
Utilisation de composés inhibant la signalisation d'apeline/apj/gp130 pour le traitement du cancer
|
US10590407B2
(en)
|
2014-04-24 |
2020-03-17 |
Nanyang Technological University |
Asx-specific protein ligase
|
WO2015184011A2
(fr)
|
2014-05-28 |
2015-12-03 |
Sanford-Burnham Medical Research Institute |
Agonistes du récepteur de l'apéline et leurs procédés d'utilisation
|
AU2015269247B2
(en)
|
2014-06-06 |
2019-10-24 |
Research Triangle Institute |
Apelin receptor (APJ) agonists and uses thereof
|
US20160058705A1
(en)
|
2014-08-28 |
2016-03-03 |
Jayakumar Rajadas |
Compositions and methods for treating cardiovascular and pulmonary diseases and disorders with apelin
|
JP6758294B2
(ja)
|
2014-12-23 |
2020-09-23 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
アペリン受容体により媒介される疾患の処置における代謝的に安定なアペリン類似体
|
US10426818B2
(en)
|
2015-03-24 |
2019-10-01 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Method and pharmaceutical composition for use in the treatment of diabetes
|
WO2016176473A1
(fr)
|
2015-04-28 |
2016-11-03 |
Sanford-Burnham Medical Researc Institute |
Agonistes du récepteur de l'apéline et leurs méthodes d'utilisation
|
KR102653667B1
(ko)
|
2015-05-20 |
2024-04-03 |
암젠 인크 |
Apj 수용체의 트라이아졸 작용제
|
HUE045546T2
(hu)
|
2015-06-03 |
2020-01-28 |
Bristol Myers Squibb Co |
4-hidroxi-3-(heteroaril)piridin-2-on APJ agonisták felhasználásra cardiovascularis megbetegedések kezelésében
|
SG10201908839QA
(en)
|
2015-10-14 |
2019-10-30 |
Bristol Myers Squibb Co |
2,4-dihydroxy-nicotinamides as apj agonists
|
WO2017091513A1
(fr)
|
2015-11-24 |
2017-06-01 |
Daiichi Sankyo Company, Limited |
Nouveaux dérivés azolés comme agoniste du récepteur de l'apéline
|
CN108473466B
(zh)
|
2015-12-04 |
2022-04-19 |
百时美施贵宝公司 |
爱帕琳肽受体激动剂及使用方法
|
BR112018011784A2
(pt)
|
2015-12-09 |
2018-12-04 |
Res Triangle Inst |
agonistas aprimorados do receptor de apelina (apj) e usos dos mesmos
|
CA3008630A1
(fr)
|
2015-12-16 |
2017-06-22 |
Bristol-Myers Squibb Company |
Heteroarylhydroxypyrimidinones en tant qu'agonistes du recepteur apj
|
MA43761A
(fr)
|
2016-03-24 |
2021-05-05 |
Bristol Myers Squibb Co |
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj
|
EP3228630A1
(fr)
|
2016-04-07 |
2017-10-11 |
IMBA-Institut für Molekulare Biotechnologie GmbH |
Combinaison d'un antagoniste d'apeline et inhibiteur de l'angiogenèse pour le traitement du cancer
|
US9988369B2
(en)
|
2016-05-03 |
2018-06-05 |
Amgen Inc. |
Heterocyclic triazole compounds as agonists of the APJ receptor
|
US10508104B2
(en)
|
2016-06-14 |
2019-12-17 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
|
US10889565B2
(en)
|
2016-06-14 |
2021-01-12 |
Bristol-Myers Squibb Company |
4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists
|
AU2017343638B2
(en)
|
2016-10-12 |
2021-12-09 |
Research Triangle Institute |
Heterocyclic apelin receptor (APJ) agonists and uses thereof
|
CN110072850B
(zh)
|
2016-10-14 |
2023-07-21 |
百时美施贵宝公司 |
3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
|
US10736883B2
(en)
|
2016-11-16 |
2020-08-11 |
Amgen Inc. |
Triazole furan compounds as agonists of the APJ receptor
|
WO2018097945A1
(fr)
|
2016-11-16 |
2018-05-31 |
Amgen Inc. |
Triazoles substitués par hétéroaryle utilisés en tant qu'agonistes du récepteur apj
|
EP3541804A1
(fr)
|
2016-11-16 |
2019-09-25 |
Amgen Inc. |
Composés de triazole à substitution cycloalkyle en tant qu'agonistes du récepteur apj
|
US10906890B2
(en)
|
2016-11-16 |
2021-02-02 |
Amgen Inc. |
Triazole phenyl compounds as agonists of the APJ receptor
|
WO2018093580A1
(fr)
|
2016-11-16 |
2018-05-24 |
Amgen Inc. |
Composés de triazole pyridyle en tant qu'agonistes du récepteur apj
|